Preparation of chitosanalginatecalcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats

Drug Development and Industrial Pharmacy

Volumn 36, Issue 8, 2010, Pages 879-884

  Onishi, Hiraku ^a   Koyama, Kennichi ^a   Sakata, Osamu ^a   MacHida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Carrageenan induced edema; Chitosanalginatecalcium complex microparticle; Lactoferrin; Release profile; Suspension state

Indexed keywords

ALGINIC ACID; CALCIUM; CARRAGEENAN; CHITOSAN; LACTOFERRIN; ANTIINFLAMMATORY AGENT; CALCIUM CHLORIDE; DRUG CARRIER; GLUCURONIC ACID; HEXURONIC ACID; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; EDEMA; IN VITRO STUDY; MALE; NONHUMAN; PH MEASUREMENT; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; PARTICLE SIZE; PH; PHARMACEUTICS; REVIEW; SCANNING ELECTRON MICROSCOPY; TIME; WISTAR RAT;

ALGINATES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM CHLORIDE; CARRAGEENAN; CHITOSAN; DRUG CARRIERS; EDEMA; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; LACTOFERRIN; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; RATS; RATS, WISTAR; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 77954205192     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903567109     Document Type: Article

References (25)

1. Weinberg ED. (1974). Iron and susceptibility to infectious disease. Science, 184(140):952-956
2. Arnold RR, Cole MF, McGhee JR. (1977). A bactericidal effect for human lactoferrin. Science, 197(4300):263-265
3. Jenssen H. (2005). Anti herpes simplex virus activity of lactofer-rin/lactoferricin\an example of antiviral activity of antimicrobial protein/peptide. Cell Mol Life Sci, 62(24):3002-3013
4. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H. (1999). Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis, 17(1):35-40.
5. Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, et al. (2002). Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol, 17(12):1291-1298 (Pubitemid 35356966)
6. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. (2004). Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci, 66(2):149-154
7. Takakura N, Wakabayashi H, Ishibashi H, Yamauchi K, Teragu-chi S, Tamura Y, et al. (2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidi-asis murine model. J Med Microbiol, 54:495-500.
8. Legrand D, Elass E, Pierce A, Mazurier J. (2004). Lactoferrin and host defence: An overview of its immuno-modulating and anti-inflammatory properties. Biometals, 17(3):225-229
9. Suzuki YA, Lopez V, Lönnerdal B. (2005). Mammalian lactofer-rin receptors: Structure and function. Cell Mol Life Sci, 62(22):2560-2575
10. Shimizu H. (2004). Development of an enteric-coated lactofer-rin tablet and its application. Biometals, 17(3):343-347
11. Takeuchi T, Jyonotsuka T, Kamemori N, Kawano G, Shimizu H, Ando K, et al. (2006). Enteric-formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats. Exp Physiol, 91(6):1033-1040
12. Ishikado A, Imanaka H, Takeuchi T, Harada E, Makino T. (2005). Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol Pharm Bull, 28(9):1717-1721
13. Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. (2000). Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol, 5(1):77-85.
14. Hori M, Onishi H, Machida Y. (2005). Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm, 297(1-2):223-234
15. Onishi H, Machida Y, Koyama K. (2007). Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparti-cles. Drug Dev Ind Pharm, 33(6):641-647
16. Oosegi T, Onishi H, Machida Y. (2008). Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. Eur J Pharm Biopharm, 68(2):260-266
17. Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. (2001). Chitosan-alginate microparticles as a protein carrier. Drug Dev Ind Pharm, 27(5):393-400.
18. Wittaya-areekul S, Kruenate J, Prahsarn C. (2006). Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm, 312(1-2):113-118
19. Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, et al. (2007). Colon-specific delivery of 5-ami-nosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm, 342(1-2):124-136
20. Basu SK, Rajendran A. (2008). Studies in the development of nateglinide loaded calcium alginate and chitosan coated calcium alginate beads. Chem Pharm Bull, 56(8):1077-1084
21. Koyama K, Onishi H, Machida Y. (2009). Preparation and in vitro evaluation of chitosan-coated alginate/calcium complex microparticles loaded with fluorescein-labeled lactoferrin. Yakugaku Zasshi, 129(12):1507-1514
22. Kubota K, Kamiya H, Kisara K, Sasaki K. (1987). Experimental pharmacology. Tokyo: Nankodo, 154-156
23. Zimecki M, Miedzybrodzki R, Szymaniec S. (1998). Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp, 46(6):361-365
24. Nezic L, Skrbic R, Dobric S, Stojiljkovic MP, Jacevic V, Satara SS, et al. (2008). Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin Pharmacol Toxicol, 104(3):185-191
25. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. (2007). Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res, 24(12):2198-2206